ERNA - CIK 0000748592
Eterna Therapeutics Inc. has filed 1,000 documents with the SEC between 2010 and 2026. The most frequent type is insider trade (317 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2022-05-27 | 2022-05-24 |
| NT 10-Q | - | 2022-05-17 | 2022-03-31 |
| 424B3 | - | 2022-05-12 | - |
| EFFECT | - | 2022-05-11 | - |
| Company correspondence | CORRESP | 2022-05-09 | - |
| SEC correspondence | UPLOAD | 2022-05-06 | - |
| Securities registration | S-3 | 2022-04-29 | - |
| Proxy materials | DEFA14A | 2022-04-26 | - |
| Proxy statement | DEF 14A | 2022-04-26 | 2022-06-07 |
| Major company event | 8-K | 2022-04-19 | 2022-04-15 |
| Major company event | 8-K | 2022-04-15 | 2022-04-15 |
| Annual report | 10-K | 2022-04-15 | 2021-12-31 |
| NT 10-K | - | 2022-04-01 | 2021-12-31 |
| D | - | 2022-03-23 | - |
| Insider trade (amended) | 4/A | 2022-03-17 | 2022-03-11 |
| Insider trade (amended) | 4/A | 2022-03-17 | 2022-03-11 |
| Insider trade (amended) | 4/A | 2022-03-17 | 2022-03-11 |
| Insider trade (amended) | 4/A | 2022-03-17 | 2022-03-11 |
| Insider trade (amended) | 4/A | 2022-03-17 | 2022-03-11 |
| Activist ownership stake (update) | SC 13D/A | 2022-03-16 | - |
| Insider trade | 4 | 2022-03-15 | 2022-03-11 |
| Insider trade | 4 | 2022-03-15 | 2022-03-11 |
| Insider trade | 4 | 2022-03-15 | 2022-03-11 |
| Insider trade | 4 | 2022-03-15 | 2022-03-11 |
| Insider trade | 4 | 2022-03-15 | 2022-03-11 |
| Major company event | 8-K | 2022-03-09 | 2022-03-06 |
| Passive ownership stake (update) | SC 13G/A | 2022-02-16 | - |
| Major company event | 8-K | 2022-01-24 | 2022-01-18 |
| Major company event | 8-K | 2022-01-20 | 2022-01-14 |
| Insider trade | 4 | 2022-01-19 | 2022-01-14 |
| Insider trade | 4 | 2022-01-19 | 2022-01-14 |
| New insider ownership | 3 | 2022-01-19 | 2022-01-14 |
| New insider ownership | 3 | 2022-01-19 | 2022-01-14 |
| Major company event | 8-K | 2022-01-05 | 2022-01-03 |
| Major company event | 8-K | 2021-12-21 | 2021-12-16 |
| Insider trade | 4 | 2021-12-10 | 2021-12-08 |
| Insider trade | 4 | 2021-12-10 | 2021-12-08 |
| Insider trade | 4 | 2021-12-10 | 2021-12-08 |
| Insider trade | 4 | 2021-12-10 | 2021-12-08 |
| EFFECT | - | 2021-11-26 | - |
| 424B3 | - | 2021-11-26 | - |
| Major company event | 8-K | 2021-11-23 | 2021-11-23 |
| Company correspondence | CORRESP | 2021-11-23 | - |
| S-1/A | - | 2021-11-23 | - |
| SEC correspondence | UPLOAD | 2021-11-22 | - |
| IPO registration | S-1 | 2021-11-18 | - |
| RW | - | 2021-11-18 | - |
| 8-A12B/A | - | 2021-11-18 | - |
| Quarterly report | 10-Q | 2021-11-12 | 2021-09-30 |
| Major company event | 8-K | 2021-11-12 | 2021-11-11 |